The fast track to innovative topical candidates
Lipidor develops improved versions of already marketed products in order to cover either unmet medical needs or improve the quality-of-life of the patient.
Lipidor is a Swedish, Stockholm based, company developing topical treatments and offering unique lipid based formulation opportunities for pharma companies. Present focus is on topical formulation candidates for psoriasis.
Lipidor develops improved versions of already marketed products in order to cover either unmet medical needs or improve the quality-of-life of the patient.
Pipeline
Lipidor is targeting to move the candidates up to proof-of-concept and thereafter license the product and the technology to partners. Licensing discussions can start at any stage.
Completed
Ongoing
Project
Indication
Research
Pre-clinical
Phase I
Phase II
Phase III
About us
The versatility of the AKVANO® delivery system has enabled the successful incorporation of more than hundred structurally different active pharmaceutical ingredients, used in different therapeutic applications.
Lipidor holds a broad IPR position relating to AKVANO® in pharma, consumer health care and animal care. The patent strategy is designed to secure the most important markets in Europe, USA, Japan, Canada and China as well as several other territories.
Lipidor has extensive experience of managing successful clinical studies. Our experience range from from pre-clinical stages to successful phase III.
Lipidor is a long-term partner with cutting-edge expertise and a strong commercial focus. To supplement our in-house competences we have formed partnerships with selected long-term collaborators within fields such as production, CRO, CMO and Commercialisation.
Collaboration
Lipidor develops improved versions of already marketed products in order to cover either unmet medical needs or improve the quality-of-life of the patient. We’re a small, highly focused organisation working with selected partners in the various phases of a project development.
The versatility of AKVANO® delivery system has enabled the successful incorporation of more than hundred structurally very different active pharmaceutical ingredients, used in different therapeutic applications. The new projects to initiate are chosen based on a number of criteria, such as patients’ needs, the potential commercial value upon success as well as its potential for a successful regulatory approval.
To deliver fast and efficient clinical studies and arrive at proof-of-concept as efficiently as possible, Lipidor works with a number of selected partners to move each candidate forward. Our network consists of carefully selected professionals as well as companies such as CRO’s, CMO’s, manufacturing partners and suppliers of clinical testing material.
Lipidor is an innovative life-science company specialized in lipid-based formulations, managing and controlling every aspect of the development process. To register and launch pharmaceuticals on specific markets Lipidor outlicense formulations to pharma companies with the ability, reach and marketing experience needed.
Contact
We’re interested in getting in touch with potential commercial partners. Please don’t hesitate to reach out to us for any questions about our technology or about our way of working.